Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 16;36(1):1-8.
doi: 10.4103/joco.joco_231_23. eCollection 2024 Jan-Mar.

Adenoid Cystic Carcinoma of the Lacrimal Gland

Celine Chaaya  1 , Georges El Haddad  1 , Fadi Abdul Karim  2   3 , Sarah Abou Daher  4
Affiliations
Review

Adenoid Cystic Carcinoma of the Lacrimal Gland

Celine Chaaya et al. J Curr Ophthalmol. .

Abstract

Purpose: To explore the various aspects of adenoid cystic carcinoma of the lacrimal gland (LACC), including its clinical features, presentations, genetic factors, as well as current and potential future treatment options.

Methods: A thorough exploration of the literature was conducted by extensively searching the PubMed database. A total of 68 articles with a primary focus on adenoid cystic carcinoma were selected.

Results: LACC is the most frequent malignant epithelial tumor of the lacrimal gland. It is characterized by the symptoms such as pain, progressive swelling of the eye, double vision, and bulging of the eye. Although LACC is a rare tumor, early detection and appropriate treatment are crucial due to its aggressive nature which includes high recurrence rate and a significant risk of mortality. The primary treatment options for LACC involve a wide range of surgical procedures, including orbitotomy, exenteration, and cranio-orbital resection. Neoadjuvant intra-arterial chemotherapy represents the paradigm shift in the treatment of LACC enhancing patient survival when compared to conventional treatments.

Conclusion: The existing literature emphasizes the importance of identifying prognostic factors that can guide treatment decisions and enhance the outcomes for patients with LACC.

Keywords: Adenoid cystic carcinoma; Genetic characteristics; Molecular aspects.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

See all similar articles

References

    1. Jaso J, Malhotra R. Adenoid cystic carcinoma. Arch Pathol Lab Med. 2011;135:511–5. - PubMed
    1. Persson M, Andrén Y, Moskaluk CA, Frierson HF, Jr, Cooke SL, Futreal PA, et al. Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma. Genes Chromosomes Cancer. 2012;51:805–17. - PubMed
    1. Lesueur P, Rapeaud E, De Marzi L, Goudjil F, Levy C, Galatoire O, et al. Adenoid cystic carcinoma of the lacrimal gland: High dose adjuvant proton therapy to improve patients outcomes. Front Oncol. 2020;10:135. - PMC - PubMed
    1. Dagher G, Anderson RL, Ossoinig KC, Baker JD. Adenoid cystic carcinoma of the lacrimal gland in a child. Arch Ophthalmol. 1980;98:1098–100. - PubMed
    1. Esmaeli B, Ahmadi MA, Youssef A, Diba R, Amato M, Myers JN, et al. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plast Reconstr Surg. 2004;20:22–6. - PubMed

LinkOut - more resources